VRCA
Verrica Pharmaceuticals Inc
4.40$
-3.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | +0.0% | -24.7% | -43.3% | +47.7% | +370.2% | |
| – | – | – | +1,167.4% | -11.0% | +106.1% | +53.6% | +2.9% | +267.3% | +25.6% | |
| – | – | – | – | – | – | -27.9% | -47.3% | +10.2% | +565.9% | |
| – | +118.3% | +243.9% | +20.3% | +1.5% | +1.6% | -23.4% | +66.4% | -41.7% | -25.2% | |
| – | +256.4% | +1,145.1% | +61.8% | +67.4% | +10.1% | -35.5% | +171.8% | +22.7% | -39.3% | |
| – | +133.0% | +390.9% | +37.5% | +32.8% | +6.2% | -30.2% | +136.9% | +0.9% | -37.7% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | -100.0% | – | – | +41.6% | -49.4% | +82.4% | +137.6% | -17.7% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -120.9% | – | +36.4% | -16.5% | -79.1% | – | – | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.